FDA to reject Mylan’s Advair Diskus generic by Selina McKee | Jun 14, 2018 | News | 0 Mylan has announced that US regulators are going to reject its generic version of GlaxoSmithKline’s asthma/COPD inhaler Advair Diskus. Read More
Setback for Vectura/Hikma’s Advair Diskus generic by Selina McKee | May 11, 2017 | News | 0 Chippenham, UK-based Vectura and its partner Hikma Pharmaceuticals have announced a major setback in the US after VR315, a generic version of GlaxoSmithKline’s asthma/COPD inhaler Advair Diskus, was rejected by the FDA. Read More